BioCentury
ARTICLE | Finance

DeciBio’s VC arm aims to further parent consultancy’s mission

Targeting smaller precision medicine companies, Los Angeles firm making cash investments, turning consulting services into equity

May 13, 2022 6:18 PM UTC

Launched by a Los Angeles consultancy, DeciBio Ventures is aiming to back precision medicine companies in a specific sweet spot: early-stage tools and therapeutics start-ups that its parent company can help strategically.

The VC is backed by DeciBio Consulting LLC, a research tools and diagnostics market intelligence company and consultancy co-founded in 2013 by two former employees of L.E.K. Consulting LLC. Stephane Budel was a senior life science specialist at L.E.K., and David Cavanaugh was a senior manager...